Yunnan Baiyao (000538.SZ) plans to invest 360 million yuan to build the Wuxi Pharmaceutical Industry Transdermal Drug Delivery Technology Industrial Platform project.

China Wisdom Financial News APP News, Yunnan Baiyao (000538.SZ) announced that the board of directors of the company approved the "Proposal on Establishing the Wuxi Pharmaceutical Industry Transdermal Drug Delivery Technology Platform Project". The company's wholly-owned subsidiary, Yunnan Baiyao Group Wuxi Pharmaceuticals Co., Ltd., will establish the Wuxi Pharmaceutical Industry Transdermal Drug Delivery Technology Industrial Platform Project. The total investment budget for the project is 360 million yuan, with the project planning core mature product supply, innovative upgraded product launch, and new dosage form research and development reserve three product pipelines, comprehensively covering core categories cultivation in the field of traumatology, expanding high-end transdermal formulations, and incubating innovative dosage forms to meet all-dimensional demands.